Vericel Corporation (VCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VCEL | KYMR | SWTX | ||
| Company | Vericel Corporation | Kymera Therapeutics Inc | Springworks Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 57.63 | 44.05 | 37.34 | ||
| High | 58.49 | 44.81 | 37.55 | ||
| Low | 56.19 | 42.87 | 36.13 | ||
| Last | 56.71 | 43.51 | 36.30 | ||
| Change | -0.55 | -0.54 | -1.14 | ||
| % Change | -0.96% | -1.23% | -3.04% | ||
| Volume | 560,300 | 510,800 | 1,475,800 | ||
| 20-Day Average Volume | 461,665 | 427,890 | 1,405,785 | ||
| Previous Close | 57.26 | 44.05 | 37.44 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 50.30 | 47.11 | 33.19 | ||
| 20-Day Raw Stochastic | 88.68% | 19.74% | 75.97% | ||
| 20-Day Relative Strength | 67.40% | 43.47% | 58.39% | ||
| Weighted Alpha | +55.42 | +57.26 | +18.26 | ||
| Today's Opinion | 56% Buy | 40% Buy | 24% Sell | ||
| Previous Opinion | 40% Buy | 40% Buy | 8% Sell | ||
| Last Month's Opinion | 88% Sell | 80% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.53% since 11/14/24 | -5.30% since 11/14/24 | -0.68% since 11/14/24 | ||
| Low | 51.53 on 11/18/24 | 41.12 on 11/18/24 | 34.29 on 11/19/24 | ||
| High | 58.49 on 11/21/24 | 45.45 on 11/15/24 | 38.58 on 11/20/24 | ||
| 1-Month | |||||
| %Chg | +37.71% since 10/21/24 | -6.55% since 10/21/24 | +19.06% since 10/21/24 | ||
| Low | 40.52 on 10/22/24 | 41.12 on 11/18/24 | 28.21 on 10/24/24 | ||
| High | 58.49 on 11/21/24 | 53.23 on 11/11/24 | 38.58 on 11/20/24 | ||
| 3-Month | |||||
| %Chg | +17.92% since 08/21/24 | -10.38% since 08/21/24 | -8.15% since 08/21/24 | ||
| Low | 39.12 on 10/10/24 | 41.12 on 11/18/24 | 28.21 on 10/24/24 | ||
| High | 58.49 on 11/21/24 | 53.27 on 09/26/24 | 43.64 on 08/26/24 | ||
| 6-Month | |||||
| %Chg | +10.05% since 05/21/24 | +23.19% since 05/21/24 | -15.54% since 05/21/24 | ||
| Low | 39.12 on 10/10/24 | 29.24 on 06/28/24 | 28.21 on 10/24/24 | ||
| High | 58.49 on 11/21/24 | 53.27 on 09/26/24 | 45.50 on 05/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,826,239 | 2,852,898 | 2,785,012 | ||
| Shares Outstanding, K | 49,358 | 64,765 | 74,386 | ||
| Annual Sales | 197,520,000 | 78,590,000 | 5,450,000 | ||
| Annual Net Income | -3,180,000 | -146,960,000 | -325,100,000 | ||
| Last Quarter Sales | 57,910,000 | 3,740,000 | 49,300,000 | ||
| Last Quarter Net Income | -900,000 | -62,490,000 | -53,530,000 | ||
| 60-Month Beta | 1.66 | 2.21 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 11/07/24 | -0.82 on 10/31/24 | -0.72 on 11/12/24 | ||
| Latest Earnings Date | 11/07/24 | 10/31/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 930.50 | 0.00 | 0.00 | ||